Pharma Market Intelligence Support
The pharma sector has transformed significantly, with most pharma and biotech companies now focusing on launching new products, developing innovative technologies, virtual clinical trials and rapid digitalisation, which are proving to be quite challenging.
Our team of subject-matter experts and significant expertise in strategic research and analysis, along with deep sector knowledge, have helped global pharma consulting and corporate clients implement tactical projects.
We conduct specialised research within the pharma space and support clients in areas such as clinical trial analysis, competitive benchmarking, pharma market intelligence, pipeline analysis, mergers and acquisitions, due diligence, strategic analysis, pharma market research, pharmaceutical competitive intelligence, pharma forecasting, sales by indication, drug launch, opportunity assessment and go-to-market strategic projects.
We empower our clients to develop and implement strategies to address the specific challenges the pharma sector faces and to keep abreast of emerging trends.
Who we serve
-
Pharma and biopharma firms -
Clinical research organisations -
Medical device and diagnostic firms -
Generic firms -
Independent consultants
Pharma Market Intelligence – Support We Offer
Market intelligence
Secondary- and primary-market research
KOL interviews
Market estimation sheets
Market sizing and forecasting
Preclinical data research
Clinical pipeline analysis
Clinical trial data evaluation
Patent landscape analysis
Conference coverage
Lifecycle management strategy
Clinical trial analysis
Drug launch
Mergers and acquisitions, and due diligence
Current and emerging treatment landscapes
Key competitors
Strategic recommendations
Analysis and insights
Opportunity assessment
Market entry and due diligence
Portfolio management/optimisation
Retail and distributor ecosystems mapping
Customer and supplier analysis
Data analytics and sales analytics
Pharma Market Intelligence – Support We Offer
Market intelligence
Secondary- and primary-market research
KOL interviews
Market estimation sheets
Market sizing and forecasting
Preclinical data research
Clinical pipeline analysis
Clinical trial data evaluation
Patent landscape analysis
Conference coverage
Lifecycle management strategy
Clinical trial analysis
Drug launch
Mergers and acquisitions, and due diligence
Current and emerging treatment landscapes
Key competitors
Strategic recommendations
Analysis and insights
Opportunity assessment
Market entry and due diligence
Portfolio management/optimisation
Retail and distributor ecosystems mapping
Customer and supplier analysis
Data analytics and sales analytics
How we are different
Excellent service offerings
High data security
Innovative technology solutions
What we have done
Assessment of GCC pharmaceutical market
What we are proud of
Analysed potential for entry into the GCC pharmaceutical market
Helped client understand socio-economic and health policies in GCC countries
Pipeline analysis and benchmarking
What we are proud of
Evaluated unmet needs to identify potential entry points
Conducted a deep-dive study of key assets and key players
Meet our experts
Thank you for sharing your details
Share this on
